New study seeks to identify who benefits from Last-Resort blood pressure drugs
NCT ID NCT07579260
First seen Jun 24, 2026 · Last updated Jun 30, 2026 · Updated 3 times
Summary
This study will follow 100 adults whose high blood pressure remains high despite taking at least two medications. Over three months, researchers will track changes in blood pressure and other health markers to find patterns that could help identify which patients might respond best to fourth-line treatments, including the FDA-approved drug aprocitentan. No new treatments are given; the goal is to gather real-world data to guide future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify which patients with resistant hypertension are most likely to benefit from newer medications like aprocitentan.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test whether any drug works, and results may not apply to all patients with hypertension.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE, HIGH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University Hospital
Durham, North Carolina, 27710, United States
-
Stanford University Hypertension Center
Palo Alto, California, 94304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?
- Can a Partner-Powered program tame high blood pressure?
- Can artery scans reveal hidden damage from high blood pressure?
- CRISPR injection could rewrite the future of blood pressure control